shot-button
Subscription Subscription
Home > Lifestyle News > Health And Fitness News > Article > Drugs delivered as liquid salt through skin reduces toxicity

Drugs delivered as liquid salt through skin reduces toxicity

Updated on: 30 December,2015 03:23 PM IST  | 
Agencies |

Formulating drugs as liquid salts may provide a safe and efficient strategy for topical delivery of drugs that cause skin toxicity, say researchers, including one of Indian-origin

Drugs delivered as liquid salt through skin reduces toxicity

liquid salt

New York: Formulating drugs as liquid salts may provide a safe and efficient strategy for topical delivery of drugs that cause skin toxicity, say researchers, including one of Indian-origin.


A novel formulation of the drug propranolol as a liquid salt enables delivery through skin with reduced toxicity, the findings showed.


Liquid salt
Representational picture


"Propranolol is positively charged which is a likely source of its toxicity. Shielding of this charge by association with a counter species in the liquid salt reduces its toxicity. These findings are broadly applicable to many charged drugs" said study senior author Samir Mitragotri, professor at University of California, Santa Barbara in the US.

Skin toxicity remains a major challenge in the design and use of new topical drug formulations. Many drugs must be dissolved in organic solvents which are typically toxic to the skin.

Many drugs such as propranolol itself show dose-dependent skin toxicity. Formulating drugs as liquid salt mitigates both sources of toxicity.

Given their fluid nature, liquid salts eliminate the necessity of organic solvents. In addition, counter ions used to form the liquid salts shield the drug charge, which further reduces drug-induced toxicity.

The researchers said that this is the first study that reports the design of liquid salts to minimise skin toxicity. Such formulations can increase the spectrum of drugs that can be safely delivered via a transdermal patch.

"This technology presents an exciting new, patient compliant solution for treating diseases," study co-author Michael Zakrewsky from University of California, Santa Barbara.

The study appeared in the journal TECHNOLOGY.

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK